Literature DB >> 28303781

Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia.

Z X Zhang1, L-H Sng2, Y Yong1, L M Lin3, T W Cheng4, N H Seong5, F K Yong6.   

Abstract

BACKGROUND: Diagnostic and treatment delays increase the severity and transmission of pulmonary tuberculosis (PTB). This study aimed to evaluate TB diagnostic and treatment delays in acid-fast bacilli (AFB) smear-negative patients.
METHODS: This was a retrospective observational study. Patients with positive AFB culture of Mycobacterium tuberculosis complex (MTC) were selected from among hospitalised patients with a diagnosis of pneumonia. Admission ward, anti-tuberculosis treatment and the duration of AFB culture were compared between smear-positive and smear-negative patients.
RESULTS: Of the 70 patients with positive isolation of MTC in AFB culture, 27 (38.5%) were smear-negative; of these, 18 (66.7%) were not isolated while in hospital, and 17 (63%) were neither diagnosed nor treated for TB. In contrast, 41 of the 43 smear-positive patients (95.3%) were directly admitted or quickly transferred to the isolation room and started on anti-tuberculosis treatment (P < 0.001). Samples from smear-negative patients required more time to grow MTC in AFB culture than those of smear-positive patients (23 days vs. 14 days, P < 0.001). Diabetes was significantly associated with AFB smear positivity, with an odds ratio of 12.2.
CONCLUSIONS: Negative AFB smears caused significant diagnostic and treatment delay. Patients staying in the general ward were exposed to TB patients who were not diagnosed in time.

Entities:  

Mesh:

Year:  2017        PMID: 28303781     DOI: 10.5588/ijtld.16.0667

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Pneumonia caused by Mycobacterium tuberculosis.

Authors:  Meili Wei; Jun Xi; Jun Wei; Bikui Tang
Journal:  Microbes Infect       Date:  2020-06-16       Impact factor: 2.700

2.  Comparison of different bacteriological testing strategies and factors for bacteriological confirmation among pulmonary TB patients: a retrospective study in Tianjin, China, 2017-2018.

Authors:  Guoqin Zhang; Yuhua Zhang; Mingting Chen; Fan Zhang
Journal:  BMC Infect Dis       Date:  2020-07-29       Impact factor: 3.090

3.  A retrospective study on Xpert MTB/RIF for detection of tuberculosis in a teaching hospital in China.

Authors:  Shuguang Li; Liyan Lin; Feifei Zhang; Chunjiang Zhao; Han Meng; Hui Wang
Journal:  BMC Infect Dis       Date:  2020-05-24       Impact factor: 3.090

4.  A retrospective review of tuberculosis exposure among health care workers in a tertiary hospital.

Authors:  Shi Zhe Gabriel Chia; Kue Bien Molly How; Maciej Piotr Chlebicki; Moi Lin Ling; Wee Hoe Gan
Journal:  Am J Infect Control       Date:  2019-12-02       Impact factor: 2.918

5.  Rapid and economical drug resistance profiling with Nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosis.

Authors:  Wai Sing Chan; Chun Hang Au; Yvonne Chung; Henry Chi Ming Leung; Dona N Ho; Elaine Yue Ling Wong; Tak Wah Lam; Tsun Leung Chan; Edmond Shiu Kwan Ma; Bone Siu Fai Tang
Journal:  BMC Res Notes       Date:  2020-09-18

6.  Determination of related factors about diagnostic and treatment delays in patients with smear-positive pulmonary tuberculosis in Turkey

Authors:  Mustafa Hamidullah Türkkani; Tarkan Özdemir; Çiğdem Özdilekcan
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

7.  Prevalence and Multi-Drug Resistance of Streptococcus pneumoniae Infection Among Presumptive Tuberculosis Adult Cases at Dilla University Referral Hospital, Dilla, Ethiopia.

Authors:  Benyiam Kaloro Halala; Musa Mohammed Ali; Moges Desta Ormago
Journal:  Infect Drug Resist       Date:  2022-09-05       Impact factor: 4.177

8.  Novel Long Non-coding RNA and LASSO Prediction Model to Better Identify Pulmonary Tuberculosis: A Case-Control Study in China.

Authors:  Zirui Meng; Minjin Wang; Shuo Guo; Yanbing Zhou; Mengyuan Lyu; Xuejiao Hu; Hao Bai; Qian Wu; Chuanmin Tao; Binwu Ying
Journal:  Front Mol Biosci       Date:  2021-05-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.